The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

Credit: Sundry Photography via Shutterstock. Boston Scientific has resumed enrolment for its AVANT GUARD clinical trial, after it was paused in October 2024to “assess a few unanticipated observations” ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy. Now, it has resumed its work to see whether its Farapulse platform can ...

The global cytology brushes market is poised for substantial growth, with projections indicating a compound annual growth ...

The annual meeting of the American College of Gastroenterology was held from Oct. 25 to 30 in Philadelphia and attracted ...

Current price $88.72 52-week high $89.01 ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...